123 results
Page 5 of 7
10-KT
3134nv 9o
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
bkcqbi0p8cn02jbra if
24 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
wrv gtn728d84y4f
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
uvb3jhlmsbbhvcayu1fm
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
l65uc api
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
a9lc7 7do8
27 Oct 14
Definitive proxy
12:00am
PRER14A
2iv6yf7
23 Oct 14
Preliminary revised proxy
12:00am
D
j94t1db37 ltc3hiz
23 Oct 14
$12.5M in equity, sold $9M, 1 investor
12:00am